Skip to main content
Top

Current Treatment Options in Oncology

Issue 6/2020

Content (9 Articles)

Ovarian Cancer Gynecologic Cancers (LA Cantrell, Section Editor)

Recurrent Treatment in Ovarian Cancer Patients: What Are the Best Regimens and the Order They Should Be Given?

Joanna Glajzer, Jacek P. Grabowski, Jalid Sehouli, Jacobus Pfisterer

Lymphoma Lymphoma (DO Persky, Section Editor)

PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma

Vladimir Sapon-Cousineau, Sasha Sapon-Cousineau, Sarit Assouline

Metastasis Skin Cancer (T Ito, Section Editor)

Current Treatment of Melanoma Brain Metastasis

Anupam Rishi, Hsiang-Hsuan Michael Yu

Actinic Keratosis Skin Cancer (T Ito, Section Editor)

The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma

Maria-Teresa Fernandez-Figueras, Luis Puig

Rituximab Leukemia (PH Wiernik, Section Editor)

Biology and Treatment of Hairy Cell Leukemia

Jérôme Paillassa, Xavier Troussard

Anemia Leukemia (PH Wiernik, Section Editor)

Management of Myelofibrosis: from Diagnosis to New Target Therapies

Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli

Metastasis Neuroendocrine Cancers (JR Strosberg, Section Editor)

Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms

Valentina Andreasi, Francesca Muffatti, Giovanni Guarneri, Massimo Falconi, Stefano Partelli

Hereditary Syndromes Neuroendocrine Cancers (JR Strosberg, Section Editor)

Hereditary Syndromes in Neuroendocrine Tumors

Mark A. Lewis

Metastasis Neuroendocrine Cancers (JR Strosberg, Section Editor)

Interventional Liver-Directed Therapy for Neuroendocrine Metastases: Current Status and Future Directions

Donna D’Souza, Jafar Golzarian, Shamar Young

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine